Reddit R&D increased by 4.2% to $207.25M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.4%, from $191.27M to $207.25M. Over 3 years (FY 2022 to FY 2025), R&D shows an upward trend with a 29.0% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $91.29M | $91.29M | $91.29M | $91.29M | $108.77M | $109.73M | $108.29M | $111.57M | $437.03M | $142.78M | $166.70M | $188.64M | $191.27M | $196.61M | $196.38M | $198.89M | $207.25M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +19.1% | +0.9% | -1.3% | +3.0% | +291.7% | -67.3% | +16.8% | +13.2% | +1.4% | +2.8% | -0.1% | +1.3% | +4.2% |
| YoY Change | — | — | — | — | +19.1% | +20.2% | +18.6% | +22.2% | +301.8% | +30.1% | +53.9% | +69.1% | -56.2% | +37.7% | +17.8% | +5.4% | +8.4% |